| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC2726 |
| Trial ID | NCT04951141 |
| Disease | Hepatocellular Carcinoma and Cholangiocarcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors |
| Year | 2021 |
| Country | China |
| Company sponsor | Beijing Immunochina Medical Science & Technology Co., Ltd. |
| Other ID(s) | 2017-003-D |
| Cohort 1 | |||||||
|
|||||||